Six African countries which are Egypt, Kenya, Nigeria, Senegal, South Africa and Tunisia will receive technology needed to produce mitochondrial ribonucleic acid (mRNA)-based COVID-19 vaccines.
It was announced by the World Health Organization (WHO), the European Council, France and South Africa on February 18, 2022.
The technology teaches the body’s own cells how to make a protein that triggers an immune response, without using any viral material.